References of "9999"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailChemical composition of colostrum from Azawak cow in Niger compared with meta-analytical data
Abdou, Harouna; Marichatou, Hamani; Beckers, Jean-François ULg et al

in Animal Genetic Resources Information = Bulletin d'Information sur les Ressources Génétiques Animales = Boletin de Informacion sobre Recursos Geneticos Animales (in press)

This study aimed at comparing data obtained from Azawak zebu colostrum with literature data. The comparison was performed by a meta-analytical approach. Colostrum samples were hand-collected after 5 h ... [more ▼]

This study aimed at comparing data obtained from Azawak zebu colostrum with literature data. The comparison was performed by a meta-analytical approach. Colostrum samples were hand-collected after 5 h from 7 Azawak cows at calving between August 27, to September 10, 2009 in the Sahel. For data from literature, twenty one (21) references were identified in the following analytical databases: PubMed, Science Direct, Google scholar, Collection from University of Liege. The references were selected according to the following two criteria: i) only studies reported on bovine colostrum were used irrespective of breeds, and ii) among the selected studies, those not providing complete information to allow meta-analytical calculation were excluded. Samples were analyzed for immunoglobulins (IgG, IgM, IgA), lactoferrin, and chemical composition (dry mater, protein, fat, lactose, ash, Ca, P, NA, K, Mg). The mean levels of IgG, IgM, dry matter, protein and fat for Azawak cows were lower (P ˂ 0.001) than those obtained in other breeds; however colostrum from the Azawak was higher in IgA but the difference was not significant. For lactose and ash, mean values for Azawak cows were higher (P ˂ 0.001) than those from the literature. Contents of Ca, P, Na and Mg in Azawak bovine colostrum were significantly higher (P ˂ 0.001) than the mean levels in form the literature data. In conclusion, the colostrum from Azawak cows appears to be lower in most immunoglobulins, in fat and in protein than the values reported in the literature, but higher in lactose and minerals. This could be an adaptation to sahelian contraints. [less ▲]

Detailed reference viewed: 20 (5 ULg)
Full Text
Peer Reviewed
See detailA l'ombre des guillotines en fleurs. Robert Desnos, la Liberté ou l'Amour (1927)
Durand, Pascal ULg

in Dubois, Jacques (Ed.) Erotique et politique dans la prose française contemporaine (in press)

Detailed reference viewed: 47 (15 ULg)
Full Text
Peer Reviewed
See detailVirtual reality as a complementary therapy to sexual addiction treatment
Cismaru Inescu, Adina; Andrianne, Robert ULg; Triffaux, Jean-Marc ULg

in International Journal of Advanced Computer Science (in press), 3(7), 1-5

Detailed reference viewed: 92 (30 ULg)
See detailLes corps saints des catacombes de Rome aux Pays-Bas : acteurs, réseaux, flux
Delfosse, Annick ULg

in Duhamelle, Christophe; Bacciochi, Stéphane (Eds.) Les corps saints des catacombes dans l’espace de la catholicité à l’âge moderne (XVIIe-XIXe siècles) (in press)

Detailed reference viewed: 15 (3 ULg)
Full Text
See detailIdentité territoriale et schizophrénie
Englebert, Jérôme ULg

in Gauthier, Jean-Marie; Weber, Yves; Vermeylen, Françoise (Eds.) et al Le corps partagé (in press)

Detailed reference viewed: 9 (5 ULg)
Full Text
Peer Reviewed
See detailÀ propos de deux pièges en psychopathologie
Englebert, Jérôme ULg

in Le Cercle Herméneutique (in press), 22

Detailed reference viewed: 16 (3 ULg)
Full Text
See detailPrise en compte de l’expérience non formelle et informelle : aperçu du contexte européen
Danse, Cédric ULg; Peters, Stéphanie ULg; Faulx, Daniel ULg

in Valorisation de l'expérience en Europe: un dispositif en construction? (in press)

Ce texte est un apreçu des structures et directives européennes visant à développer la Formation Tout au Long de la Vie (Lifelong Learning) au travers de la reconnaissance des acquis non formels et ... [more ▼]

Ce texte est un apreçu des structures et directives européennes visant à développer la Formation Tout au Long de la Vie (Lifelong Learning) au travers de la reconnaissance des acquis non formels et infomels. Nous disctuons également des logiques qui sous-tendent l'application d'une telle politique. [less ▲]

Detailed reference viewed: 107 (38 ULg)
Full Text
See detailValorisation et validation de l’expérience et des compétences : pratiques en Belgique francophone
Danse, Cédric ULg; Peters, Stéphanie ULg; Faulx, Daniel ULg

in Valorisation de l'expérience en Europe: un dispositif en construction? (in press)

La valorisation de l'expérience connaît un développement considérable, en particulier depuis les accords de Lisbonne concernant la Formation Tout au Long de la Vie (FTLV) dans les années 2000. Située au ... [more ▼]

La valorisation de l'expérience connaît un développement considérable, en particulier depuis les accords de Lisbonne concernant la Formation Tout au Long de la Vie (FTLV) dans les années 2000. Située au confluent de stratégies individuelle, organisationnelle, nationale et continuentale, la reconnaissance des apprentissages non formels et informels, dont les avancées diffèrent selon les états membres de l'UE, est au coeur des attentions. Pour mieux saisir le développement en Belgique francophone de la prise en compte de l'expérience des individus, le présent chapitre dresse le paysage des strucutures officielles permettant de valoriser voire valider les compétences acquises par les individus tout au long de leur vie. [less ▲]

Detailed reference viewed: 305 (55 ULg)
Full Text
Peer Reviewed
See detailLe "Gate fever" : cristallisation et fossilisation de l’univers carcéral
Englebert, Jérôme ULg

in Sami-Ali; Cady, Sylvie (Eds.) Temporalité et psychosomatique (in press)

Detailed reference viewed: 27 (2 ULg)
Full Text
Peer Reviewed
See detailA European survey on attitudes towards pain and end-of-life issues in locked-in syndrome
Demertzi, Athina ULg; Jox, Ralf J; Racine, Eric et al

in Brain Injury (in press)

Objectives: Patients with locked-in syndrome often self-report a higher quality of life than generally expected. This study reports third-person attitudes towards several salient issues on locked-in ... [more ▼]

Objectives: Patients with locked-in syndrome often self-report a higher quality of life than generally expected. This study reports third-person attitudes towards several salient issues on locked-in syndrome. Methods: Close-ended survey among conference attendees from 33 European countries. Analysis included chi-square tests and logistic regressions. Results: From the 3332 respondents (33% physicians, 18% other clinicians, 49% other professions; 47% religious), 90% agreed that patients with locked-in syndrome can feel pain. The majority (75%) disagreed with treatment withdrawal, but 56% did not wish to be kept alive if they imagined themselves in this condition (p50.001). Religious and southern Europeans opposed to treatment withdrawal more often than non-religious (p50.001) and participants from the North (p¼0.001). When the locked-in syndrome was compared to disorders of consciousness, more respondents endorsed that being in a chronic locked-in syndrome was worse than being in a vegetative state or minimally conscious state for patients (59%) than they thought for families (40%, p50.001). Conclusions: Personal characteristics mediate opinions about locked-in syndrome. The dissociation between personal preferences and general opinions underlie the difference in perspective in disability. Ethical responses to dilemmas involving patients with locked-in syndrome should consider the diverging ethical attitudes of stakeholders. [less ▲]

Detailed reference viewed: 48 (3 ULg)
Peer Reviewed
See detailOrganic Rankine Cycles including fluid selection
Lemort, Vincent ULg; Declaye, Sébastien ULg; Quoilin, Sylvain ULg

in Handbook of Clean Energy Systems (in press)

An Organic Rankine Cycle (ORC) is similar to a steam Rankine cycle, except that the working fluid is not water but an organic compound, such as a refrigerant or a hydrocarbon, characterized by a lower ... [more ▼]

An Organic Rankine Cycle (ORC) is similar to a steam Rankine cycle, except that the working fluid is not water but an organic compound, such as a refrigerant or a hydrocarbon, characterized by a lower ebullition temperature than that of water. Hence lower temperature heat sources can be exploited such as solar energy, geothermal energy and waste heat recovery from many different processes. During the design phase of an ORC system, the selection of the working fluid must be conducted in parallel with the selection and the sizing of the components (mainly the expansion machine, the pump and the heat exchangers) and with the definition of the cycle architecture. This approach allows taking into consideration all technical constraints. Relevant properties of working fluids that should be considered during their selection are listed. Major characteristics of available displacement and turbo-expander technologies are described. The impact of the pump performance on the overall performance is discussed and strategies to increase the available NPSH are proposed. Finally, improved cycle architectures are introduced. Major applications of ORC systems are described: geothermal power plants, biomass CHP plants, waste heat recovery in industry, waste heat recovery on internal combustion engines and solar power plants. All these applications differ by the nature of the heat source and heat sink, the integration of the ORC with these sources and sinks, and the range of installed capacities. These differences yield specific designs, which are described. Performance achieved by systems in operation or prototypes are presented. [less ▲]

Detailed reference viewed: 98 (20 ULg)
Full Text
Peer Reviewed
See detailEnjeux politiques et critiques d'une philosophie des normes
Caeymaex, Florence ULg; Pieron, Julien ULg

in Dissensus (in press), 6(printemps 2014),

Detailed reference viewed: 13 (0 ULg)
Full Text
Peer Reviewed
See detailSpazio scritto e spazio non scritto nelle dossografie mediche su papiro
Ricciardetto, Antonio ULg

in Spazio scritto e spazio non scritto nel libro papiraceo: esperienze a confronto (in press)

Detailed reference viewed: 8 (0 ULg)
Full Text
Peer Reviewed
See detailAllogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT
Basak, GW.; Wiktor-Jedrzejczak, W.; Labopin, M. et al

in American Journal of Transplantation (in press)

We conducted a questionnaire survey of the 565 European Society for Blood and Marrow Transplantation centers to analyze the outcome of allogeneic hematopoietic stem cell transplantation (alloSCT) in ... [more ▼]

We conducted a questionnaire survey of the 565 European Society for Blood and Marrow Transplantation centers to analyze the outcome of allogeneic hematopoietic stem cell transplantation (alloSCT) in recipients of solid organ transplantation (SOT). We investigated 28 patients with malignant (N=22) or nonmalignant diseases (N=6), who underwent 31 alloSCT procedures: 12 after kidney, 13 after liver, and three after heart transplantation. The incidence of solid organ graft failure at 60 months after first alloSCT was 33% (95% confidence interval [CI], 16–51%) for all patients, 15% (95% CI, 2–40%) for liver recipients, and 50% (95% CI, 19–75%) for kidney recipients (p = 0.06). The relapse rate after alloSCT (22%) was low following transplantation for malignant disorders, despite advanced stages of malignancy. Overall survival at 60 months after first alloSCT was 40% (95% CI, 19–60%) for all patients, 51% (95% CI, 16–86%) for liver recipients, and 42% (95% CI, 14–70%) for kidney recipients (p = 0.39). In summary, we show that selected SOT recipients suffering from hematologic disorders may benefit from alloSCT and experience enhanced long-term survival without loss of organ function. [less ▲]

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detailPractical management of Chronic Myeloid Leukemia in Belgium
Benghiat, FS.; Beguin, Yves ULg; Dessars, B. et al

in Belgian Journal of Hematology (in press)

Imatinib has drastically changed the outcome of patients with chronic myeloid leukemia (CML), with the majority of them showing a normal life span. Recently, the development of second and third generation ... [more ▼]

Imatinib has drastically changed the outcome of patients with chronic myeloid leukemia (CML), with the majority of them showing a normal life span. Recently, the development of second and third generation tyrosine kinase inhibitors (TKIs) and the possibility of treatment discontinuation made the management of these patients more challenging. In this review, practical management guidelines of CML are presented, adapted to the Belgian situation in 2014. In first line chronic phase patients, imatinib, nilotinib and dasatinib can be prescribed. While second generation TKIs give faster and deeper responses, their impact on long-term survival remain to be determined. The choice of the TKI depends on CML risk score, priority for a deep response to allow a treatment-free remission protocol, age, presence of comorbid conditions, side effect profile, drug interactions, compliance concerns and price. Monitoring the response has to be made according the 2013 ELN criteria, and is based on the bone-marrow cytogenetic response during the first months and on the blood molecular response. Molecular follow-up is sufficient in patients with a complete cytogenetic response. For patients who fail frontline therapy, nilotinib, dasatinib, bosutinib and ponatinib are an option depending of the type of intolerance or resistance. T315I patients are only sensitive to ponatinib, which has to be carefully handled due to cardiovascular toxicity. Advanced phase diseases are more difficult to handle, with treatments including allogeneic stem cell transplantation, which is also an option for patients failing at least two TKIs. The possibility of treatment-free remission and pregnancy are also discussed. [less ▲]

Detailed reference viewed: 15 (0 ULg)
Full Text
Peer Reviewed
See detailBHS guidelines for the treatment of Burkitt lymphoma
BONNET, Christophe ULg; Janssens, A.; Wu, KL. et al

in Belgian Journal of Hematology (in press)

Burkitt lymphoma (BL) is a rare but very aggressive non-Hodgkin’s lymphoma characterized by an isolated translocation t(8;14)(q24;q32). The sporadic form is the subentity most frequently encountered in ... [more ▼]

Burkitt lymphoma (BL) is a rare but very aggressive non-Hodgkin’s lymphoma characterized by an isolated translocation t(8;14)(q24;q32). The sporadic form is the subentity most frequently encountered in our country. Diagnosis and initial work-up must be completed rapidly to start treatment as soon as possible. Positron emission tomography (PET) scan is useful for initial staging and to evaluate the chemosensitivity of the tumor during and after treatment. After debulking, it is recommended to add rituximab to chemotherapy. Currently intensive short-cycle chemotherapies (ISCC) and low intensity chemotherapies (LIC) are two valuable options. Radiotherapy is not indicated except in case of central nervous system involvement. Patients achieving complete remission must be followed carefully during the first year to detect recurrence of the disease. More than 80% of patients sustain their remission one year following initial treatment and are considered cured. For patients in partial remission or with chemosensitive relapse, autologous stem cell transplantation is recommended following re-induction with non-cross-resistant polychemotherapy. Monitoring complete blood counts and cognitive functions is important to detect late toxicity of the applied therapies. [less ▲]

Detailed reference viewed: 10 (1 ULg)
Full Text
Peer Reviewed
See detailRituximab therapy for hairy cell leukemia : a retrospective study of 41 cases
Leclerc, Mathieu; Suarez, Felipe; Noël, Marie-Pierre et al

in Annals of Hematology (in press)

The purine analogs (PAs) cladribine and pentostatin have transformed the prognosis of hairy cell leukemia (HCL). However, some patients still relapse after PAs, or fail to reach an optimal response, and ... [more ▼]

The purine analogs (PAs) cladribine and pentostatin have transformed the prognosis of hairy cell leukemia (HCL). However, some patients still relapse after PAs, or fail to reach an optimal response, and new agents are needed to further improve treatment outcome. We retrospectively studied 41 HCL patients from 10 centers in France and Belgium, who received 49 treatment courses with the anti-CD20 monoclonal antibody rituximab. Most of the patients were treated at relapse (84 % of cases) and rituximab was combined to a PA in 41 % of cases. Overall, response rate is 90 % including 71 % complete hematologic responses (CHRs). Frontline treatment, combination therapy, and absolute neutrophil count were associated with response in multivariate analysis. Three-year relapse-free and overall survivals are 68 and 90 %, respectively. When combined to a PA, rituximab yields a 100 % response rate, even beyond frontline therapy. In contrast, response rate is only 82 % (59 % CHR) when rituximab is used alone. In this latter setting, relapse rate is 56 % and median time to relapse is 17.5 months. All eight patients who were treated two times with the antibody responded again to retreatment. We confirm the high efficacy of the combination rituximab + PA. However, when rituximab is used as monotherapy, response rate is lower and the high relapse rate is a concern. Prospective clinical trials are needed to confirm the superiority of the combination rituximab + PA over PA alone, both as frontline therapy and at relapse. [less ▲]

Detailed reference viewed: 7 (0 ULg)
Full Text
Peer Reviewed
See detailSputum cytokines levels in patients undergoing hematopoietic SCT (HSCT) and comparison with healthy subjects and COPD: a pilot study
MOERMANS, Catherine ULg; BONNET, Christophe ULg; WILLEMS, Evelyne ULg et al

in Bone Marrow Transplantation (in press)

Patients undergoing hematopoietic stem cell transplantation (HSCT) display an airway neutrophilic inflammation before the transplantation that persists over the years. In this study, we have investigated ... [more ▼]

Patients undergoing hematopoietic stem cell transplantation (HSCT) display an airway neutrophilic inflammation before the transplantation that persists over the years. In this study, we have investigated the cytokine profile over a period of one year in sputum supernatant of patients who underwent HSCT. We have measured sputum supernatant levels of TNF-α, TGF-β1, IL-4, IL-5, IL-6, IL-8, IL-10, IL-13, IL-17, and IFN-γ in 49 HSCT patients and compared the results with those found in 40 COPD and 54 healthy subjects matched for age. Compared to healthy subjects, before the transplantation, HSCT patients exhibited raised levels of IL-6 (p<0.001) and IL-8 (p<0.05) while the other cytokines were generally poorly detectable. This picture was rather similar to what is seen in COPD even if cytokine levels were much greater in the latter with IL-8 being significantly greater in COPD than in HSCT patients (p<0.0001). In the 1 year following the transplantation, sputum IL-6 and IL-8 did not differ any longer compared to healthy subjects. Overall in HSCT patients, sputum IL-8 and IL-6 correlated with sputum neutrophil counts (r=0.4, p<0.0001; r=0.42, p<0.0001, respectively). In conclusion, sputum IL-6 and IL-8 may play a role in neutrophilic airway inflammation seen in patients undergoing HSCT. [less ▲]

Detailed reference viewed: 11 (5 ULg)
Full Text
Peer Reviewed
See detailManagement of osteoporosis of the oldest old.
Rizzoli, R.; Branco, J.; Brandi, M.-L. et al

in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (in press)

This consensus article reviews the diagnosis and treatment of osteoporosis in geriatric populations. Specifically, it reviews the risk assessment and intervention thresholds, the impact of nutritional ... [more ▼]

This consensus article reviews the diagnosis and treatment of osteoporosis in geriatric populations. Specifically, it reviews the risk assessment and intervention thresholds, the impact of nutritional deficiencies, fall prevention strategies, pharmacological treatments and their safety considerations, the risks of sub-optimal treatment adherence and strategies for its improvement. INTRODUCTION: This consensus article reviews the therapeutic strategies and management options for the treatment of osteoporosis of the oldest old. This vulnerable segment (persons over 80 years of age) stands to gain substantially from effective anti-osteoporosis treatment, but the under-prescription of these treatments is frequent. METHODS: This report is the result of an ESCEO (European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis) expert working group, which explores some of the reasons for this and presents the arguments to counter these beliefs. The risk assessment of older individuals is briefly reviewed along with the differences between some intervention guidelines. The current evidence on the impact of nutritional deficiencies (i.e. calcium, protein and vitamin D) is presented, as are strategies to prevent falls. One possible reason for the under-prescription of pharmacological treatments for osteoporosis in the oldest old is the perception that anti-fracture efficacy requires long-term treatment. However, a review of the data shows convincing anti-fracture efficacy already by 12 months. RESULTS: The safety profiles of these pharmacological agents are generally satisfactory in this patient segment provided a few precautions are followed. CONCLUSION: These patients should be considered for particular consultation/follow-up procedures in the effort to convince on the benefits of treatment and to allay fears of adverse drug reactions, since poor adherence is a major problem for the success of a strategy for osteoporosis and limits cost-effectiveness. [less ▲]

Detailed reference viewed: 10 (4 ULg)
Peer Reviewed
See detailDescribing the ‘elusive’ : Availability, Preparation and Use of Anthocyanin Colourants in Mediaeval European Illuminators’ Workshops
Neven, Sylvie ULg; Sanyova, Jana

in Dubois, Hélène; Eyb-Green, Sigrid; Kroustallis, Stephanos (Eds.) et al Making and transforming art : changes in artists’ materials and practice (in press)

Anthocyanins are colorants which provide most of the blue, red and violet colours in numerous plants and fruits. Because of their great sensitivity to the slightest changes in pH and their instability in ... [more ▼]

Anthocyanins are colorants which provide most of the blue, red and violet colours in numerous plants and fruits. Because of their great sensitivity to the slightest changes in pH and their instability in ordinary daylight, it is generally thought that these colorants were used only to dye everyday clothes in a domestic context. However, medieval artists’ recipe books not only describe these elusive substances, but also indicate their use in illumination. This is notably the case for the texts of the so-called ‘Strasbourg Tradition’, written in the south of Germany and the north of France between 1400 and 1560, and partly composed from an older Alsatian treatise on illumination. Departing from these sources, this paper details the methods employed to prepare these colorants and (re)evaluates their diverse uses in painting and illuminating techniques. This technical data subsequently served as a basis upon which to make reconstructions. Finally, an attempt to correlate the information provided by these recipe books with specific artistic practices was carried out by collating the descriptions with the results of analyses from contemporary illuminations by an Alsatian workshop active in the same geographical area. [less ▲]

Detailed reference viewed: 23 (5 ULg)